Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet

被引:77
|
作者
Abenavoli, Ludovico [1 ]
Milic, Natasa [2 ]
Peta, Valentina [1 ]
Alfieri, Francesco [3 ]
De Lorenzo, Antonino [4 ]
Bellentani, Stefano [5 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy
[2] Univ Novi Sad, Dept Pharm, Novi Sad 21000, Serbia
[3] Univ MEIER, I-20124 Baranzate Di Bollate, MI, Italy
[4] Univ Roma Tor Vergata, Dept Biomed & Prevent, Div Clin Nutr & Nutrigen, I-00133 Rome, Italy
[5] Azienda USL Modena, Ramazzini Hosp, I-42100 Carpi, Modena, Italy
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Insulin resistance; Nutrition; Mediterranean diet; HEPATIC INSULIN-RESISTANCE; LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; RISK-FACTORS; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; OXIDATIVE-STRESS; CONTROLLED-TRIAL; IRON STORES; STEATOHEPATITIS;
D O I
10.3748/wjg.v20.i45.16831
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The mechanisms of the underlying disease development and progression are awaiting clarification. Insulin resistance and obesity-related inflammation status, among other possible genetic, dietary, and lifestyle factors, are thought to play the key role. There is no consensus concerning the pharmacological treatment. However, the dietary nutritional management to achieve weight loss is an essential component of any treatment strategy. On the basis of its components, the literature reports on the effectiveness of the Mediterranean diet in reducing cardio-vascular risk and in preventing major chronic diseases, including obesity and diabetes. New evidence supports the idea that the Mediterranean diet, associated with physical activity and cognitive behaviour therapy, may have an important role in the prevention and the treatment of NAFLD. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:16831 / 16840
页数:10
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [42] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [43] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [44] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [45] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [46] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [47] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [48] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [49] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [50] Diet and non-alcoholic fatty liver disease, a short narrative review
    Kwanten, W. J.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (01) : 306 - 310